Datadog to Present at Upcoming Investor Conferences
Get Alerts DDOG Hot Sheet
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Datadog, Inc. (NASDAQ: DDOG), the monitoring and analytics platform for developers, IT operations teams and business users in the cloud age, today announced that management will present at the following investor conferences.
- The J.P. Morgan Global Technology, Media and Communications Conference. The presentation is scheduled for Wednesday, May 13, 2020 at 2:40 p.m., Eastern Time.
- The William Blair Growth Stock Conference. The presentation is scheduled for Tuesday, June 9, 2020 at 1:00 p.m., Eastern Time.
The presentations will be webcast live, and replays will be available for a limited time under the “Events and Presentations” section of the Company’s investor relations website at https://investors.datadoghq.com/.
About Datadog
Datadog is the monitoring and analytics platform for developers, IT operations teams and business users in the cloud age. Our SaaS platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide unified, real-time observability of our customers' entire technology stack. Datadog is used by organizations of all sizes and across a wide range of industries to enable digital transformation and cloud migration, drive collaboration among development, operations and business teams, accelerate time to market for applications, reduce time to problem resolution, understand user behavior and track key business metrics.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200506005050/en/
AJ Ljubich, CFA
Datadog Investor Relations
(866) 329-4466
[email protected]
Martin Bergman
Datadog Communications
(866) 329-4466
[email protected]
Source: Datadog, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Datadog (DDOG) PT Raised to Street High $330 at Benchmark
- EverGen Infrastructure Announces Share Issuance to Officers and Directors of the Company
- Cyllene Therapeutics (formerly known as EG 427) Raises €33 Million Series C Financing to Advance Clinical Development of EG110A and Pipeline Expansion
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
William Blair, JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share